iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Sun Pharma Boosts Taro Pharma Buyout Offer to $43 per Share

12 Dec 2023 , 09:47 AM

Sun Pharma revises offer price for acquiring Taro Pharma’s outstanding shares to $43 per share, a 13% increase from the initial $38 per share proposal. On December 11, Sun Pharma shares settled flat at Rs 1,235.3 per share on the NSE.  At the time of writing the stock was trading at Rs 1235.30 in NSE.

Taro Pharma’s shares surged 29% on the proposal, closing at the initial offer price of $38 per share. Extended trading hours saw an additional 8.6% increase. Ongoing negotiations for definitive terms and agreements related to the revised proposal; no assurance of reaching a definitive agreement.

The revised proposal is subject to further corporate approvals and satisfaction of customary conditions.

Sun Pharma expressed interest on May 26 to acquire all Taro Pharma shares, aiming for 100% ownership in an all-cash transaction.

Taro Pharma reported a net profit of $8.5 million for the July-September quarter, compared to a net loss of $2.8 million the previous year, with the bottom line slightly impacted by one-time exceptional charges.

For feedback and suggestions, write to us at editorial@iifl.com

 

Related Tags

  • Sun Pharma
  • Sun Pharma news
  • Sun Pharma Updates
  • Taro Pharma
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.